期刊文献+

来自医院感染患者标本的鲍曼不动杆菌耐药性分析 被引量:4

Drug-resistance analysis of Acinetobacter baumannii in clinical infection
下载PDF
导出
摘要 目的分析来自医院感染患者标本的鲍曼不动杆菌的耐药性。方法对281株鲍曼不动杆菌进行药敏试验,药敏结果采用WHONET5.6软件进行回顾性分析。结果 2012年~2014年鲍曼不动杆菌对多黏菌素B敏感率一直为100%,对阿米卡星的敏感率分别为18.6%、37.1%和41.4%,对复方新诺明的敏感率分别为28.0%、38.1%和41.4%,3年对亚胺培南耐药率均高于69%,对美洛培南的耐药率均高于70%。结论来自医院感染患者标本的鲍曼不动杆菌对多黏菌素B敏感率高,对亚胺培南、美洛培南的耐药率高。 Objective To analyze the drug-resistance of Acinetobacter baumannii in the clinical infection. Methods The drug sensitive test was conducted in 281 bacterial isolates of Acinetobacter baumannii,and the results were retrospectively analyzed by software WHONET 5. 6. Results It was showed that in 2012,2013 and 2014 the sensitivity rates to polymyxin B of Acinetobacter baumannii were always 100%. The sensitivity rates to amikacin were 18. 6%,37. 1% and 41. 4%,respectively.The sensitivity rates to cotrimoxazole were 28. 0%,38. 1% and 41. 4%,respectively. In the last three years,the resistance rates to imipenem were all above 69% and meropenem were all above 70%. Conclusion There were high sensitivity rates of Acinetobacter baumannii to polymyxin B and high resistance rates to imipenem and meropenem.
出处 《山东医药》 CAS 北大核心 2015年第31期39-41,共3页 Shandong Medical Journal
基金 国家科技支撑计划基金资助项目(2012EP001000)
关键词 鲍曼不动杆菌 细菌耐药 抗菌药物 Acinetobacter baumannii bacterial resistance anti-bacterial agents
  • 相关文献

参考文献9

二级参考文献43

  • 1陈敏章 邵丙扬 王海燕 等.中华内科学[M].北京:人民卫生出版社,1999.2502.
  • 2Graven DE, Stegerka, ventilator associated bacterial pneumonia Challenges in diagnosis, treatment, and prevention [ J ]. NewHoriz, 1998, 6 : S30-S45.
  • 3Eliting LS, Khardori N, Bodey GP, et al. Nosocomial infection caused by Xan Thomonas Maltophilia: a case - control study of predisposing factor[J ]. Infect Control. Hosp. Epidemiol, 1990,11 : 134-138.
  • 4Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty- first informational supplement. MIO0 - $20, 2011.
  • 5Doi Y, Husain S, Potoski B, et al. Extensively drug-resistant Acin- etobacter baumannii[J]. Emerg Infect Dis,2009,15(6) : 980-982.
  • 6Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria:an update[J]. Drugs,2009,69(12) : 1555-1623.
  • 7Leonard DA,Bonomo RA,Powers RA. Class D beta-Laetamases.. a reappraisal after five decades[J]. Acc Chem Res, 2013,46 (11) 2407-2415.
  • 8Krizova L, Poirel L, Nordmann P, et ah TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobact er baumannii[J]. J Antimicrob Chemother, 2013, 68 ( 12 ) : 2786- 2791.
  • 9H uys G,Cnockaert M, Vaneeehoutte M, et al. Distribution of tet- racycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different Eu- ropean hospitals[J]. Res Microbiol, 2005,156(3) : 348-355.
  • 10Perez F,Endimiani A,Bonomo RA. Why are we afraid of Acineto- baeter baumannii[J]. Expert Rev Anti Infect Ther, 2008,6 (3): 269-271.

共引文献146

同被引文献43

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部